BRIEF-EMA Recommends Restricting Use Of Tecovirimat SIGA

Reuters03-27

March 27 (Reuters) - EMA:

EMA RECOMMENDS RESTRICTING USE OF TECOVIRIMAT SIGA
EMA: CHMP HAS RECOMMENDED THAT TECOVIRIMAT SIGA SHOULD NO LONGER BE USED FOR TREATMENT OF MPOX - WEBSITE
EMA: REVIEW DID NOT IDENTIFY ANY NEW SAFETY CONCERNS ASSOCIATED WITH TECOVIRIMAT SIGA

((Reuters.Briefs@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2622826503?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-27 19:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2622826503","market":"us","top_or_hot":-1,"title":"BRIEF-EMA Recommends Restricting Use Of Tecovirimat SIGA","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-EMA Recommends Restricting Use Of Tecovirimat SIGA</title></head><body><p><span>March 27 (Reuters)</span><span> - </span>EMA:</p><ul><li><p>EMA RECOMMENDS RESTRICTING USE OF TECOVIRIMAT SIGA</p></li><li><p>EMA: CHMP HAS RECOMMENDED THAT TECOVIRIMAT SIGA SHOULD NO LONGER BE USED FOR TREATMENT OF MPOX - WEBSITE</p></li><li><p>EMA: REVIEW DID NOT IDENTIFY ANY NEW SAFETY CONCERNS ASSOCIATED WITH TECOVIRIMAT SIGA</p></li></ul><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-EMA Recommends Restricting Use Of Tecovirimat SIGA</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-EMA Recommends Restricting Use Of Tecovirimat SIGA\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-27 19:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-EMA Recommends Restricting Use Of Tecovirimat SIGA</title></head><body><p><span>March 27 (Reuters)</span><span> - </span>EMA:</p><ul><li><p>EMA RECOMMENDS RESTRICTING USE OF TECOVIRIMAT SIGA</p></li><li><p>EMA: CHMP HAS RECOMMENDED THAT TECOVIRIMAT SIGA SHOULD NO LONGER BE USED FOR TREATMENT OF MPOX - WEBSITE</p></li><li><p>EMA: REVIEW DID NOT IDENTIFY ANY NEW SAFETY CONCERNS ASSOCIATED WITH TECOVIRIMAT SIGA</p></li></ul><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nFWN40F0HA:1","article_id":"2622826503","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2622826503","pubTimestamp":1774612694,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-EMA Recommends Restricting Use Of Tecovirimat SIGAMarch 27  - EMA:EMA RECOMMENDS RESTRICTING USE OF TECOVIRIMAT SIGAEMA: CHMP HAS RECOMMENDED THAT TECOVIRIMAT SIGA SHOULD NO LONGER BE USED FOR TREATMENT OF MPOX - WEBSITEEMA: REVIEW DID NOT IDENTIFY ANY NEW SAFETY CONCERNS ASSOCIATED WITH TECOVIRIMAT SIGA ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","SIGA":"SIGA Technologies Inc","BK4583":"猴痘概念"},"translate_title":"简报-EMA建议限制Tecovirimat SIGA的使用","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SIGA":0.9},"content_text":"BRIEF-EMA Recommends Restricting Use Of Tecovirimat SIGAMarch 27 (Reuters) - EMA:EMA RECOMMENDS RESTRICTING USE OF TECOVIRIMAT SIGAEMA: CHMP HAS RECOMMENDED THAT TECOVIRIMAT SIGA SHOULD NO LONGER BE USED FOR TREATMENT OF MPOX - WEBSITEEMA: REVIEW DID NOT IDENTIFY ANY NEW SAFETY CONCERNS ASSOCIATED WITH TECOVIRIMAT SIGA ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"policyRegulatory","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2622826503","isCrawlerRequest":true}